FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly//File Photo Dec 9 (Reuters) - The U.S.
The FDA has approved Augmentin XR, an oral antibacterial, under its Commissioner’s National Priority Voucher pilot program, marking the first approval granted through the expedited review pathway. The ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has cleared the first medicine under its new National Priority Voucher program, approving a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results